I'll work through this step-by-step, identifying the relevant industry and calculating the S&P-adjusted debt-to-EBITDA ratio for A2A ENERGIA S.P.A.

## Step 1: Identify the Relevant Industry

A2A ENERGIA S.P.A. is an Italian multi-utility company. Looking at the methodologies provided:
- It's not purely "Regulated Utilities" (though it has regulated components)
- It's not "Oil And Gas Exploration And Production"
- It's not "Transportation Infrastructure"

The entity fits best under **"Unregulated Power And Gas"** or a hybrid of regulated/unregulated utilities. Given A2A's business model (electricity and gas generation, distribution, and supply), I'll apply the **general corporate baseline formulas** with consideration for utility-specific adjustments where relevant. The company appears to have both regulated and unregulated activities.

Actually, re-reading: A2A is described as a multi-utility with both regulated network activities and unregulated generation/supply. Given the data shows significant revenue from contracts and commodity exposure, I'll primarily use the **general corporate baseline** with relevant utility adjustments.

## Step 2: Estimate Adjusted_Debt

### Reported Debt Components:
From the balance sheet, I need to identify debt-like items:

**Noncurrent Financial Liabilities:**
- Other Noncurrent Financial Liabilities (2022-01-01): 4,322,000,000 EUR
- Other Noncurrent Financial Liabilities (2023-01-01): 5,867,000,000 EUR

**Current Financial Liabilities:**
- Other Current Financial Liabilities (2022-01-01): 746,000,000 EUR
- Other Current Financial Liabilities (2023-01-01): 1,022,000,000 EUR

**Total Reported Debt at year-end 2022 (which is 2023-01-01):**
- Noncurrent financial liabilities: 5,867,000,000 EUR
- Current financial liabilities: 1,022,000,000 EUR
- **Total: 6,889,000,000 EUR**

Wait - let me re-check. The dates show 2023-01-01 as the year-end for 2022 fiscal year. So I'll use 2023-01-01 figures for year-end 2022.

**Reported Debt (year-end 2022):**
- Other Noncurrent Financial Liabilities: 5,867,000,000 EUR
- Other Current Financial Liabilities: 1,022,000,000 EUR
- **Total Reported Debt: 6,889,000,000 EUR**

### Other Debt-Like Items:

**Pension Deficit:**
- Noncurrent Provisions For Employee Benefits (2023-01-01): 248,000,000 EUR
- Noncurrent Provisions For Employee Benefits (2022-01-01): 294,000,000 EUR

These are employee benefit obligations. For S&P purposes, pension deficits are added to debt. I'll use the year-end figure: **248,000,000 EUR**

**Leases:**
Looking through the data, I don't see explicit lease liabilities separated out. The "Payments Of Lease Liabilities Classified As Financing Activities" shows 11,000,000 EUR for 2022, indicating leases exist. However, without explicit lease liability figures on the balance sheet, I'll need to estimate or note that this may be embedded in other financial liabilities.

Given the data limitations and that IFRS 16 lease liabilities are typically included in financial liabilities, I'll assume leases are largely captured in reported debt, but I should add a modest estimate. Looking at the cash flow statement, lease payments are 11,000,000 EUR. A rough estimate of lease liability might be around 50-100 million EUR based on typical lease terms. However, given uncertainty, I'll use a conservative estimate.

Actually, re-examining: in many European utilities, lease liabilities are included in "Other Noncurrent Financial Liabilities" and "Other Current Financial Liabilities." Without explicit separation, I'll proceed with reported figures but note this may understate slightly.

Let me check if there are other items:
- No explicit guarantees mentioned
- No hybrid debt mentioned
- No securitization mentioned

**Other Longterm Provisions:**
- Other Longterm Provisions (2023-01-01): 729,000,000 EUR
- Other Longterm Provisions (2022-01-01): 797,000,000 EUR

These could include decommissioning, environmental, etc. S&P sometimes treats certain provisions as debt-like if they represent unavoidable obligations. For utilities, asset retirement obligations and similar can be debt-like. I'll include a portion - typically 50-100% depending on nature. Given this is a multi-utility, I'll treat **50% as debt-like: 364,500,000 EUR**

**Cash and Equivalents to Deduct:**
- Cash And Cash Equivalents (2023-01-01): 2,584,000,000 EUR

However, S&P typically only deducts "eligible cash" - cash that is truly excess and available. For utilities, they often haircut cash. I'll apply a standard approach: deduct 75% of cash as "eligible" or use full cash if clearly excess.

Actually, standard S&P practice is to deduct cash and liquid investments, but sometimes with adjustments for operational needs. For a utility with seasonal working capital needs, I'll deduct the full cash but note this may be aggressive.

**Adjusted_Debt Calculation:**

| Component | Amount (EUR) |
|-----------|-------------|
| Reported Debt (noncurrent + current financial liabilities) | 6,889,000,000 |
| Pension Deficit (Noncurrent Provisions For Employee Benefits) | 248,000,000 |
| 50% of Other Longterm Provisions | 364,500,000 |
| Estimated Lease Liabilities (not separately reported, conservative) | 100,000,000 |
| **Subtotal Gross Debt-Like Items** | **7,601,500,000** |
| Less: Cash and Cash Equivalents | (2,584,000,000) |
| **Adjusted_Debt** | **5,017,500,000** |

Wait - let me reconsider. The Other Longterm Provisions may already include pension items. Let me re-check: "Noncurrent Provisions For Employee Benefits" is separate from "Other Longterm Provisions." So they are distinct.

Also, I need to be more careful about lease liabilities. Given IFRS 16, these should be in financial liabilities. Let me assume they're included and not add separately, or add a smaller amount for operating leases not yet captured.

Revised approach - more conservative:
- Use reported financial liabilities as base
- Add pension deficit
- Add portion of other provisions that are debt-like (decommissioning, environmental)
- Deduct cash

Let me check if there are any "Liabilities Included In Disposal Groups Classified As Held For Sale" - these are 0 at year-end 2022.

**Revised Adjusted_Debt:**

| Component | Amount (EUR) |
|-----------|-------------|
| Noncurrent Financial Liabilities | 5,867,000,000 |
| Current Financial Liabilities | 1,022,000,000 |
| Noncurrent Provisions For Employee Benefits | 248,000,000 |
| 50% Other Longterm Provisions | 364,500,000 |
| **Total Gross** | **7,501,500,000** |
| Less: Cash and Cash Equivalents | (2,584,000,000) |
| **Adjusted_Debt** | **4,917,500,000** |

I'll round to **4,918,000,000 EUR** or use precise: 4,917,500,000 EUR

## Step 3: Estimate Adjusted_EBITDA

### Reported EBITDA:
From the income statement:
- "Gross Operating Income EBITDA" (2022-01-01 - 2023-01-01): **1,505,000,000 EUR**

This is the reported EBITDA for fiscal year 2022.

### Adjustments to EBITDA:

**Nonrecurring Items:**
- "Result From Nonrecurring Transactions" (2022-01-01 - 2023-01-01): 157,000,000 EUR (positive)

This is a gain. S&P typically:
- Adds back nonrecurring losses
- Subtracts nonrecurring gains

So we **subtract 157,000,000 EUR** from EBITDA.

**Joint Venture Adjustments:**
- "Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method": 2,000,000 EUR (positive)

For proportional consolidation, S&P may adjust to include proportional EBITDA rather than just equity income. However, without detailed JV balance sheets, this is complex. The equity income is small relative to total EBITDA. I'll make a simplified adjustment: for equity-accounted JVs, S&P typically adds back the equity income and adds proportional debt/EBITDA. Given limited data, I'll add a modest adjustment.

Actually, the standard approach is to replace equity income with proportional EBITDA. If we assume JVs have similar margins, proportional EBITDA might be roughly 2-3x equity income. But without data, I'll use a simplified approach and add back equity income (to remove it) and make no further adjustment, or add a small amount.

Given the small size (2M vs 1505M), this is immaterial. I'll **add back 2,000,000 EUR** to remove equity income effect, then assume proportional EBITDA is similar.

Actually, simpler: S&P's standard for equity investments is to add proportional share of EBITDA and proportional share of debt. Without detailed data, I'll note this is small and make minimal adjustment.

**Pension Adjustments:**
For defined benefit plans, S&P may adjust EBITDA to replace service cost with cash contributions, or to normalize pension costs. Given limited data, and that the pension provision is relatively small, I'll make no material adjustment.

**Lease Adjustments:**
If we capitalized leases, we'd add back lease expense to EBITDA. Given IFRS 16, lease expense is largely depreciation/interest rather than operating expense. Minimal EBITDA adjustment needed.

**Other Normalization:**
- The company had significant working capital changes and commodity price impacts in 2022 due to energy crisis. Revenue nearly doubled from 11.5B to 23.2B EUR, largely due to pass-through commodity costs.

For a utility with significant pass-through costs, S&P may look at "underlying" EBITDA excluding working capital timing effects. However, the reported EBITDA already reflects this.

Let me check if EBITDA margin is distorted by pass-through: Revenue went from 11.5B to 23.2B, but EBITDA only from 1.43B to 1.51B. This suggests massive commodity cost pass-through with minimal margin.

Actually, looking more carefully: "Raw Materials And Consumables Used" went from 9.1B to 20.5B, roughly matching revenue increase. This is typical for energy retailers/suppliers.

For S&P purposes, they may adjust for "purchased power" or pass-through costs that distort metrics. In the Regulated Utilities section, they mention: "For integrated electric utilities that meet native load obligations partly by using third-party power contracts, we use our purchased power methodology to adjust measures for such contracts' debt-like obligations."

However, this is complex and requires knowing the split. I'll proceed with reported EBITDA but note it may be conservative.

**Adjusted_EBITDA Calculation:**

| Component | Amount (EUR) |
|-----------|-------------|
| Reported EBITDA | 1,505,000,000 |
| Less: Nonrecurring gain | (157,000,000) |
| Add back: Equity income (to replace with proportional) | 2,000,000 |
| Estimated proportional EBITDA from JVs (rough) | 4,000,000 |
| **Adjusted_EBITDA** | **1,354,000,000** |

Wait - let me reconsider the JV treatment. Standard S&P approach for equity-accounted investments:
- Remove equity income from EBITDA
- Add proportional share of JV EBITDA
- Add proportional share of JV debt to Adjusted Debt

Given we don't have JV financials, and the equity income is only 2M, I'll simplify:
- Remove the 2M equity income (it's below EBITDA line anyway, but affects EBIT)
- For EBITDA, since equity income is after operating profit, it doesn't affect EBITDA directly

Actually, re-reading: "Share Of Profit Loss Of Associates And Joint Ventures" is typically shown after operating profit. So it doesn't affect EBITDA. No EBITDA adjustment needed for this item.

Revised:
| Component | Amount (EUR) |
|-----------|-------------|
| Reported EBITDA | 1,505,000,000 |
| Less: Nonrecurring gain | (157,000,000) |
| **Adjusted_EBITDA** | **1,348,000,000** |

Let me verify the nonrecurring item: "Result From Nonrecurring Transactions" of 157M - is this a gain or loss? It's positive, so it's a gain. S&P subtracts nonrecurring gains.

However, I should check if this is already in EBITDA or below it. Looking at the structure:
- EBITDA: 1,505M
- Depreciation etc: 818M
- Operating profit: 687M
- Then nonrecurring: 157M

Wait, the ordering suggests "Result From Nonrecurring Transactions" might be after operating profit. Let me re-read:

"Profit Loss From Operating Activities" = 687M
"Result From Nonrecurring Transactions" = 157M

So nonrecurring is after operating profit. Is it included in EBITDA? EBITDA is "Gross Operating Income EBITDA" = 1505M. Then after depreciation (818M), we get operating profit of 687M. Then nonrecurring 157M.

So nonrecurring is NOT in EBITDA. Therefore, no EBITDA adjustment needed for this item - it's already excluded.

But wait - S&P may want to adjust for nonrecurring items that are in or near EBITDA. Since this is below operating profit, it's not in EBITDA. However, if S&P reconstructs EBITDA from operating profit, they might treat this differently.

Actually, standard S&P EBITDA reconstruction: EBIT + Depreciation + Amortization. If nonrecurring is part of EBIT or below, we need to check.

"Profit Loss From Operating Activities" = 687M. This likely includes nonrecurring or excludes it. Looking at typical Italian reporting, "Risultato della gestione caratteristica" or similar may include or exclude nonrecurring.

Given the explicit "Gross Operating Income EBITDA" line, I'll use that as starting point. The nonrecurring 157M is likely not in EBITDA.

However, S&P may still normalize for nonrecurring items if they represent true one-offs that should be excluded from run-rate. Since it's a gain, and if it's not in EBITDA, we don't subtract it from EBITDA. But if we're trying to get "sustainable" EBITDA, and this gain flows through to net income but not EBITDA, no adjustment needed.

Actually, let me reconsider: some nonrecurring items might be in "Other Revenue" or "Other Expense" that are above EBITDA. The 157M "Result From Nonrecurring Transactions" is explicitly labeled as nonrecurring and is below operating profit.

I'll use **Adjusted_EBITDA = 1,505,000,000 EUR** with minimal adjustments, or perhaps adjust for any nonrecurring items embedded in EBITDA.

Looking at "Other Revenue" of 220M - this might include some nonrecurring items. But without detail, I'll use reported EBITDA.

However, let me check if there are working capital or timing effects that distort 2022 EBITDA. The massive revenue increase suggests commodity price passthrough. S&P sometimes adjusts EBITDA for utilities to remove timing mismatches in passthrough.

Given the complexity and limited data, I'll use a pragmatic approach:
- Base EBITDA: 1,505M
- Less: Estimate of nonrecurring gains embedded (conservative 50M, given 157M explicit below line)
- Or use as-is if we believe EBITDA is clean

Actually, looking at cash flow: "Adjustments For Losses Gains On Disposal Of Noncurrent Assets" = -191M (negative means gain). This 191M gain is likely part of the 157M nonrecurring or related. This is definitely nonrecurring.

Is this gain in EBITDA? Gains on disposal are typically below EBITDA (in operating profit or below). So likely not in EBITDA.

I'll proceed with **Adjusted_EBITDA = 1,505,000,000 EUR** but note we might need to adjust for sustainable run-rate. Given the energy crisis in 2022 with extreme commodity prices and potential margin squeezes, 2022 EBITDA might not be fully representative.

Alternatively, S&P might use average or normalized EBITDA. But per instructions, I should use 2022 actuals.

Let me also consider: should I add back pension service cost? S&P sometimes adds back defined benefit pension service cost to EBITDA (replacing with cash contribution). Without detailed pension data, I'll estimate.

"Noncurrent Provisions For Employee Benefits" decreased from 294M to 248M, suggesting some utilization. Cash contributions vs service cost unknown. I'll make no adjustment given data limitations.

Final Adjusted_EBITDA: I'll use **1,505,000,000 EUR** as base, and consider if nonrecurring items above the line need adjustment.

Actually, re-examining: "Other Expense By Nature" = 394M. This includes various items. "Adjustments For Provisions" in cash flow = 92M. Hard to parse.

I'll use a conservative approach: **Adjusted_EBITDA = 1,505,000,000 - 50,000,000 (estimated nonrecurring in EBITDA) = 1,455,000,000 EUR**

Or more simply, use reported and accept it may include some nonrecurring.

Given the explicit nonrecurring is below EBITDA line, I'll use **1,505,000,000 EUR** as Adjusted_EBITDA.

## Step 4: Calculate Adjusted_Debt / Adjusted_EBITDA

Using my estimates:
- Adjusted_Debt: 4,917,500,000 EUR
- Adjusted_EBITDA: 1,505,000,000 EUR

Ratio = 4,917,500,000 / 1,505,000,000 = **3.267**

Or with rounded numbers: 4,918 / 1,505 = 3.268

Let me recalculate with slightly different assumptions to check sensitivity:

If I don't include 50% of other longterm provisions (treat as true operating provisions):
- Adjusted_Debt = 4,917,500,000 - 364,500,000 = 4,553,000,000
- Ratio = 4,553 / 1,505 = 3.025

If I include 100% of other longterm provisions:
- Adjusted_Debt = 4,917,500,000 + 364,500,000 = 5,282,000,000
- Ratio = 5,282 / 1,505 = 3.510

If I deduct only 50% of cash (more conservative, keeping some for operations):
- Adjusted_Debt = 4,917,500,000 + 1,292,000,000 = 6,209,500,000
- Ratio = 6,210 / 1,505 = 4.127

Given S&P typical practice for utilities, full cash deduction is often applied if cash is clearly excess. But in 2022 with energy crisis, high cash might be needed for collateral/margin calls.

Let me check working capital: Current assets increased massively from 8.6B to 11.1B (excl held for sale), with receivables up from 3.3B to 4.7B and inventories from 204M to 536M. Current liabilities also up from 8.1B to 9.7B with payables from 2.9B to 5.5B. This suggests significant working capital needs.

Given this, perhaps not all cash is excess. But S&P typically still deducts cash for leverage ratios.

I'll stick with my base case but refine:

**Refined Adjusted_Debt:**
- Financial liabilities (noncurrent + current): 6,889M
- Plus: Pension deficit (employee benefits provision): 248M  
- Plus: 50% other longterm provisions (debt-like portion): 364.5M
- Less: Cash and equivalents: (2,584M)
- **Adjusted_Debt = 4,917.5M EUR**

**Refined Adjusted_EBITDA:**
- Reported EBITDA: 1,505M
- Less: Nonrecurring gains (if any in EBITDA - using 0 as explicit nonrecurring is below line)
- **Adjusted_EBITDA = 1,505M EUR**

Ratio = 4,917.5 / 1,505 = **3.2675**

Rounding to two decimal places: **3.27**

However, let me reconsider if I should make EBITDA adjustments for the nonrecurring 157M gain. Even though it's below operating profit, S&P's "Adjusted_EBITDA" formula says "+ nonrecurring_losses - nonrecurring_gains ± other_normalization_adjustments". 

If the 157M nonrecurring gain is not in EBITDA, we don't subtract it from EBITDA. But if we're computing from a base that includes it, we would. Since "Gross Operating Income EBITDA" is explicitly stated and the nonrecurring is a separate line below operating profit, it's not in the 1,505M.

But wait - let me re-check the Italian financial statement structure. "Risultato della gestione non ricorrente" or similar might be placed differently. Looking at the ordering:
- EBITDA: 1,505M
- Depreciation etc: 818M  
- Operating profit: 687M
- Result From Nonrecurring Transactions: 157M

So operating profit (687M) = EBITDA (1505M) - Depreciation (818M). Then nonrecurring 157M is added to get to a subtotal before financial items.

So: 687M + 157M = 844M, then finance items, etc.

This confirms nonrecurring is NOT in EBITDA.

Final calculation: 4,917.5 / 1,505 = 3.2675 ≈ **3.27**

Let me also verify with an alternative: if we use average of 2021 and 2022 EBITDA for normalization:
- 2021 EBITDA: 1,428M
- 2022 EBITDA: 1,505M
- Average: 1,466.5M
- Ratio: 4,917.5 / 1,466.5 = 3.35

But per instructions, use 2022 figures.

One more check: should I include discontinued operations EBITDA? "Profit Loss From Discontinued Operations" = 36M. This is net income, not EBITDA. If discontinued ops contributed to EBITDA, it might be in the 1,505M or separate. Given it's "discontinued," S&P might exclude. But without detail, I'll assume 1,505M is for continuing ops or combined as reported.

Actually, looking at structure: "Profit Loss From Continuing Operations" = 412M, "Profit Loss From Discontinued Operations" = 36M, total "Profit Loss" = 448M. The EBITDA line likely covers total operations (continuing + discontinued) as it's "Gross Operating Income" at consolidated level.

Given immaterial size of discontinued (36M vs 412M continuing), impact is small.

**Final Answer:**

<answer>3.27</answer>